Morgan Stanley »

Aim Immunotech shares owned by Morgan Stanley

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $32k 85k 0.37
2024-03-31 $40k 85k 0.47
2023-12-31 $34k 77k 0.44
2023-09-30 $115k 252k 0.46
2023-06-30 $292k 436k 0.67
2022-12-31 $286k 917k 0.31
2022-06-30 $1.2M 1.6M 0.78
2022-03-31 $2.1M 2.0M 1.06
2021-06-30 $5.4M 2.5M 2.15
2020-12-31 $1.8M 999k 1.79
2020-09-30 $1.7M 805k 2.15
2020-06-30 $1.2M 476k 2.48
2020-03-31 $46k 18k 2.53
2019-12-31 $0 76 0.00
2019-09-30 $109k 144k 0.76